Calidi Biotherapeutics

(NYSEMKT) CLDI

Current Price$0.21

Market Cap$2.31M

Since IPO (2021)-100%

5 YearN/A

1 Year-96%

1 Month-10%

Calidi Biotherapeutics Financials at a Glance

Market Cap

$2.31M

Revenue (TTM)

$0.00

Net Income (TTM)

$19.91M

EPS (TTM)

$-6.96

P/E Ratio

-0.03

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Price

$0.21

Volume

9,950

Open

$0.21

Price

$0.21

Volume

9,950

Open

$0.21

Previous Close

$0.21

Daily Range

$0.21 - $0.21

52-Week Range

$0.19 - $19.20

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Price

$0.21

Volume

9,950

Open

$0.21

Previous Close

$0.21

Daily Range

$0.21 - $0.21

52-Week Range

$0.19 - $19.20

CLDI News

Calidi Loss Down 23 Percent in Fiscal Q2

Motley Fool Markets TeamAug 8, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Calidi Biotherapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Eric E. Poma, PhD, MBA

Website

www.calidibio.com

Headquarters

San Diego, CA 92121, US

CLDI Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-967%

Return on Capital

-4%

Return on Assets

-2%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.31M

Shares Outstanding

10.90M

Volume

9.95K

Avg. Volume

3.63M

Financials (TTM)

Gross Profit

$1.65M

Operating Income

$20.24M

EBITDA

$18.59M

Operating Cash Flow

$21.29M

Capital Expenditure

$120.00K

Free Cash Flow

$21.41M

Cash & ST Invst.

$5.60M

Total Debt

$2.56M

Calidi Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$423.00K

-7.6%

Gross Margin

0.00%

N/A

Market Cap

$2.31M

N/A

Market Cap/Employee

$82.50K

N/A

Employees

N/A

Net Income

$4.06M

+1.0%

EBITDA

$4.04M

-13.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$3.64M

+42.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$448.00K

-82.7%

Short Term Debt

$1.52M

-65.9%

Return on Assets

-2.25%

N/A

Return on Invested Capital

-4.11%

N/A

Free Cash Flow

$5.07M

+6.5%

Operating Cash Flow

$5.04M

+7.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TTNPTitan Pharmaceuticals, Inc.

TTNPTitan Pharmaceuticals, Inc.$2.34-11.36%

SNGXSoligenix, Inc.

SNGXSoligenix, Inc.$0.32-7.80%

SXTP60 Degrees Pharmaceuticals, Inc.

SXTP60 Degrees Pharmaceuticals, Inc.$1.64+1.55%

SILOSilo Pharma, Inc.

SILOSilo Pharma, Inc.$0.45-2.17%

CNSPCNS Pharmaceuticals, Inc.

CNSPCNS Pharmaceuticals, Inc.$7.12-9.18%

CMNDClearmind Medicine Inc.

CMNDClearmind Medicine Inc.$0.60-10.37%

XBIOXenetic Biosciences, Inc.

XBIOXenetic Biosciences, Inc.$3.09+4.39%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

DGXXDigi Power X

DGXXDigi Power X$5.33+0.35%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.83+0.02%

BLZEBackblaze

BLZEBackblaze$7.63+0.65%

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF$8.54-0.05%

SMCISuper Micro Computer

SMCISuper Micro Computer$27.80-0.00%

BBBlackBerry

BBBlackBerry$5.62+0.01%

INTCIntel

INTCIntel$108.16+0.13%

Questions About CLDI

What is the current price of Calidi Biotherapeutics?

Calidi Biotherapeutics is trading at $0.21 per share.

What is the 52-week range for Calidi Biotherapeutics?

Over the past 52 weeks, Calidi Biotherapeutics has traded between $0.19 and $19.20.

How much debt does Calidi Biotherapeutics have?

As of the most recent reporting period, Calidi Biotherapeutics reported total debt of $2.56M.

How much cash does Calidi Biotherapeutics have on hand?

Calidi Biotherapeutics reported $5.70M in cash and cash equivalents in its most recent financial results.

What is Calidi Biotherapeutics’s dividend yield?

Calidi Biotherapeutics does not currently have a dividend yield.

Calidi Biotherapeutics

Calidi Biotherapeutics Financials at a Glance

CLDI News

Calidi Loss Down 23 Percent in Fiscal Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Calidi Biotherapeutics

CLDI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Calidi Biotherapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CLDI

What is the current price of Calidi Biotherapeutics?

What is the 52-week range for Calidi Biotherapeutics?

How much debt does Calidi Biotherapeutics have?

How much cash does Calidi Biotherapeutics have on hand?

What is Calidi Biotherapeutics’s dividend yield?

Premium Investing Services